In addition, CCRCC patients with negative VEGFR2 expression demonstrated poor disease-specific survival (hazard ratio: 3.602, 95% confidence interval: 0.117–0.658, p-value = 0.004) (Table 3). This evidence concerns the gene KDR and nonpapillary renal cell carcinoma.